NCT05737888

Brief Summary

The present project involves research on humans with the aim to characterize the reduction of chronic, continuous, non-pulsatile and debilitating tinnitus in humans by comparing neurofeedback (fMRI or EEG) to the current gold standard behavioral cognitive therapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 14, 2017

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 6, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 10, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 21, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2023

Completed
Last Updated

November 14, 2023

Status Verified

November 1, 2023

Enrollment Period

5.8 years

First QC Date

February 10, 2023

Last Update Submit

November 13, 2023

Conditions

Keywords

TinnitusEEG neurofeedbackfMRI neurofeedbackCognitive behavioral therapy

Outcome Measures

Primary Outcomes (1)

  • Behavioral improvement of tinnitus as measured by the Tinnitus Handicap Inventory (THI)

    To show that behavioral improvement of tinnitus after intensive neurofeedback training is equivalent or better than improvement obtained after attending group cognitive behavioral therapy, as measured by Tinnitus Handicap Inventory (THI) scores reported before experiment and at late post-assessment (significant difference, p-value \< 0.05). THI ranges from low scores (grade 1 - slight or no handicap), to highest scores (grade 5 - catastrophic handicap).

    8 months

Secondary Outcomes (6)

  • Audiological measures

    8 months

  • Training effect

    8 months

  • Other factors

    8 months

  • Correlation with BOLD signal

    8 months

  • Correlation with alpha activity

    8 months

  • +1 more secondary outcomes

Study Arms (3)

fMRI Neurofeedback

EXPERIMENTAL

The participants receive visual feedback (displayed on a screen) related to BOLD activity from their auditory cortices, and they are asked to learn to down-regulate it.

Other: fMRI Neurofeedback

EEG Neurofeedback

EXPERIMENTAL

The participants receive visual feedback (displayed on a screen) related to the ratio of alpha to delta localized activity from their auditory cortices, and they are asked to learn to up-regulate it.

Other: EEG Neurofeedback

Cognitive Behavioral Therapy

ACTIVE COMPARATOR

Group therapy is provided by trained clinicians for research participants. Participants are confronted with tinnitus-inducting situations and trained to use diverse cognitive and behavioral coping skills to reduce the subjective impact of tinnitus burden. Such coping skills include relaxation, distraction, and de-catastrophizing, among other strategies.

Behavioral: Cognitive Behavioral Therapy

Interventions

15 intervention sessions on a 3T MRI scanner.

fMRI Neurofeedback

15 intervention sessions with a standard EEG-cap with 64 active electrodes.

EEG Neurofeedback

10 intervention sessions of CBT group therapy, as per local university hospital standard of care.

Cognitive Behavioral Therapy

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18 to 80 years
  • Tinnitus Handicap Inventory ≥ 48
  • Chronic, persistent, non-pulsatile tinnitus for minimum 6 months
  • Functional hearing
  • Normal inner ear structure assessment using an ear microscope, normal tympanic membrane mobility
  • Participant willing, able and available to participate in the entire research, including completion of questionnaires and traveling to research sites for the duration of the trial

You may not qualify if:

  • Contraindication to MRI (e.g. non compatible cochlear implant, pacemaker, deep brain stimulation)
  • Conductive hearing loss exceeding 20 dB at two or more frequencies
  • Known diagnoses causing tinnitus or hearing loss:
  • Known systemic disease (vestibular schwannoma, endolymphatic hydrops)
  • Lesion in central nervous system, including history of severe cranio-cerebral trauma
  • Acute ear canal or middle ear inflammation or effusion
  • Significant neurologic disease, psychiatric disease, substance abuse or acute allergic disease
  • Ongoing medication that is known to treat, influence, or cause tinnitus (e.g. high-dose aspirin, quinidine, aminoglycosides)
  • Ongoing or recent (completed since less than 4 weeks) tinnitus therapy (e.g. tinnitus maskers, acupuncture)
  • Participation in competitive or pharmacological study
  • Pregnant woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dept. of Otology, Audiology and Cochlear Implant Surgery, University Hospital Geneva

Geneva, Canton of Geneva, 1205, Switzerland

Location

Related Publications (1)

  • Gninenko N, Trznadel S, Daskalou D, Gramatica L, Vanoy J, Voruz F, Robyn CL, Spadazzi A, Yulzari A, Sitaram R, Van De Ville D, Senn P, Haller S. Functional MRI Neurofeedback Outperforms Cognitive Behavioral Therapy for Reducing Tinnitus Distress: A Prospective Randomized Clinical Trial. Radiology. 2024 Feb;310(2):e231143. doi: 10.1148/radiol.231143.

MeSH Terms

Conditions

Tinnitus

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Pascal Senn, MD, PhD

    Dept. of Otology, Audiology and Cochlear Implant Surgery, University Hospital Geneva

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective research with 3 independent research arms.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 10, 2023

First Posted

February 21, 2023

Study Start

February 14, 2017

Primary Completion

December 6, 2022

Study Completion

March 30, 2023

Last Updated

November 14, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations